requip-modutab 2 mg prolonged-release tablets
glaxosmithkline (ireland) limited - ropinirole hydrochloride - prolonged-release tablet - 2 milligram(s) - dopamine agonists; ropinirole
requip-modutab 8mg prolonged-release tablets
pco manufacturing ltd. - ropinirole hydrochloride - prolonged-release tablet - 8 milligram(s) - dopamine agonists; ropinirole
requip-modutab 2 mg prolonged-release tablets
ltt pharma limited - ropinirole - prolonged-release tablet - 2 milligram(s) - dopamine agonists; ropinirole
requip-modutab 8 mg prolonged-release tablets
ltt pharma limited - ropinirole - prolonged-release tablet - 8 milligram(s) - dopamine agonists; ropinirole
requip-modutab 8 mg prolonged-release tablets
glaxosmithkline (ireland) limited - ropinirole hydrochloride - prolonged-release tablet - 8 milligram(s) - dopamine agonists; ropinirole
requip-modutab 4 mg prolonged-release tablets
ltt pharma limited - ropinirole - prolonged-release tablet - 4 milligram(s) - dopamine agonists; ropinirole
requip-modutab 4 mg prolonged-release tablets
glaxosmithkline (ireland) limited - ropinirole hydrochloride - prolonged-release tablet - 4 milligram(s) - dopamine agonists; ropinirole
requip-modutab 4 mg prolonged-release tablets
pco manufacturing ltd. - ropinirole hydrochloride - prolonged-release tablet - 4 milligram(s) - dopamine agonists; ropinirole
seretide 25/250 microgram pressurised inhalation suspension
clear pharmacy - salmeterol, fluticasone propionate - pressurised inhalation suspension - 25/250 microgram - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
seretide 250 evohaler 25 microgram/250 microgram/dose pressurised inhalation, suspension
pco manufacturing ltd. - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - 25/250 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone